News

Filter

Current filters:

None

7975 to 7984 of 97217 results

Barriers to overcome in lupus drug development

22-07-2012

It has taken the lupus research community over 50 years to produce a new therapy. Although it is now…

Anthera PharmaceuticalsBenlystaBiotechnologyblisibimodGlaxoSmithKlineImmunologicalsPharmaceuticalResearch

Infinity regains global rights to PI3K, FAAH; equity investment by Purdue

20-07-2012

USA-based Infinity Pharmaceuticals (Nasdaq: INFI) says it has restructured its strategic alliance with…

FinancialInfinity PharmaceuticalsLicensingMundipharmaPharmaceuticalPurdue PharmaResearch

Bristol-Myers brivanib fails in Ph III liver cancer trial

20-07-2012

US drug major Bristol-Myers Squibb (NYSE: BMY) yesterday reported results of the Phase III BRISK-FL clinical…

Bristol-Myers SquibbbrivanibNexavarOncologyPharmaceuticalResearch

EMA accepts Pfizer's bazedoxifene/CE marketing application

20-07-2012

The European Medicines Agency has accepted for review drug behemoth Pfizer's (NYSE: PFE) Marketing Authorization…

Anti-Arthritics/RheumaticsbazedoxifeneEuropePfizerPharmaceuticalRegulationWomen's Health

Actelion hikes earnings outlook despite lower sales

20-07-2012

Switzerland-based Actelion (ATLN: VX), Europe's largest biotech company, reported first-half 2012 financial…

ActelionBiotechnologyFinancial

Dr Reddy's posts 28% revenue growth for fiscal 1st-qtr 2013

20-07-2012

India's second largest drugmaker Dr Reddy's Laboratories (NYSE: RDY) yesterday released unaudited consolidated…

Dr Reddy's LaboratoriesFinancialGenerics

Pharmaceutical supply chain in Japan sees squeezed margins

19-07-2012

Pressures felt in Japan as a result of the country's aging population, drug price revisions and patent…

Asia-PacificBiotechnologyFinancialMarkets & MarketingMergers & AcquisitionsPharmaceuticalPricing

Domestic HIV funding outpaces international investments

19-07-2012

A new report by the Joint United Nations Program on HIV/AIDS (UNAIDS) shows that domestic funding for…

Anti-viralsFinancialGlobalHealthcarePharmaceutical

Alimera's Iluvien approved in France for diabetic macular edema

19-07-2012

USA-based ophthalmic biopharma specialist Alimera Sciences (Nasdaq: ALIM) says that French regulator…

Alimera SciencesEuropeFinancialIluvienOphthalmicsPharmaceuticalRegulation

7975 to 7984 of 97217 results

Back to top